• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Persistent chemotherapy-induced alopecia was more severe with the use of taxanes in breast cancer survivors

byKathleen Lau
October 7, 2021
in StudyGraphics
0
Share on FacebookShare on Twitter

RELATED REPORTS

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

Tags: alopeciabreastBreast Cancerbreast cancer survivalcabazitaxelcancercancer survivalchemochemotherapychemotherapy-induced alopeciacicatricial alopeciadermdermatologydiffuse non-scarring alopeciadocetaxelfemale pattern hair losshairhair lossmale pattern hair lossoncologypaclitaxelpersistent chemotherapy-induced alopeciasinclairskintaxane
Previous Post

#VisualAbstract: Dose-escalated intensity-modulated radiotherapy does not improve survival for patients with laryngeal or hypopharyngeal cancers

Next Post

Active search for pulmonary embolism does not change outcomes in patients with chronic obstructive pulmonary disease exacerbation

RelatedReports

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation
Pharma

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

August 20, 2025
Radiation plus hormone therapy may improve prostate cancer survival
Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025
Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients
Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025
Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors
Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025
Next Post
2 Minute Medicine Rewind May 20, 2019

Active search for pulmonary embolism does not change outcomes in patients with chronic obstructive pulmonary disease exacerbation

No obesity paradox found between BMI, stroke, and death

Less physical activity and more screen time is associated with poorer mental health in children and adolescents

Why Is Everyone Reading The Decameron Right Now?

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague
  • Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths
  • Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.